Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
80
¥ millionWording
Definitive
How definitive the wording is.Notice Regarding the Recording of a Gain on Sale of Investment Securities (Extraordinary Income)
Subject Entity
わかもと製薬株式会社
Target Locations / Products
上場有価証券１銘柄
Occurrence3 December 2024
This disclosure12/04/2024
Cause
保有資産の効率化を図るため、当社が保有する投資有価証券の一部を売却したこと
Amount of Impact on Business Performance
80百万円（特別利益）
Accounting period in which recognized
2025年3月期第３四半期
Outlook
上記投資有価証券売却益につきましては、2025年3月期第３四半期決算において投資有価証券売却益80百万円を特別利益として計上いたします。
| Item | Details |
|---|---|
| Event name | Notice Regarding the Recording of a Gain on Sale of Investment Securities (Extraordinary Income) |
| Date of occurrence | 3 December 2024 |
| Subject Entity | わかもと製薬株式会社 |
| Target Locations / Products | 上場有価証券１銘柄 |
| Cause | 保有資産の効率化を図るため、当社が保有する投資有価証券の一部を売却したこと |
| Amount of Impact on Business Performance | 80百万円（特別利益） |
| Accounting period in which recognized | 2025年3月期第３四半期 |
| Outlook | 上記投資有価証券売却益につきましては、2025年3月期第３四半期決算において投資有価証券売却益80百万円を特別利益として計上いたします。 |
Items this document does not state (17)
Date recognized / date notice receivedImpact on Earnings ForecastType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To improve the efficiency of our asset holdings.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.